Public Production of Medicines’ Law

From June 2011, Argentina has a public production of medicines law.

This law was unanimously passed by the Argentine´s Senate. The research and public production of medicines, vaccines, medical device and drugs for production of medicines are declared of national interest. The law considers all these as common goods.

It proposes scientific and technology development through public laboratories.

Also, it promotes the research, the development and the production of orphan medicines.

The public laboratories can sign agreements with the universities to do quality control of medicines, vaccine and medical device.

LIF will produce Sildenafil

LIF is making research and development of Sildenafil syrup and tablets.

Syldenafil syrup is an orphan medicine used to treat Pulmonary Arterial Hypertension (PAH)* of the newborn. This is developed with the Rosario’s National University, School of Sciences Biochemical and Pharmaceutical.

On the other hand LIF is working on the development of Sildenafil tablets used to treat erectile dysfunction.

* PAH is a rare disease with an incidence of about 2-3 per million per year and a prevalence of about 15 per million. Adult females are almost three times as likely to present with PAH as adult males. The presentation of IPAH within children is more evenly split along gender lines. (N. Rudarakanchana, R C Trembath, N. W. Morrel. New insights into the pathogenesis and treatment of primary pulmonary hypertension)